Cargando…
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
OBJECTIVES: Stereotactic body radiotherapy (SBRT) is a definitive local treatment option for patients with stage I non-small cell lung cancer (NSCLC) who are not surgical candidates and patients who refuse surgery. The purpose of this study was to assess the impact of SBRT on T1–T2 NSCLC from a nati...
Autores principales: | Davis, Joanne N., Medbery, Clinton, Sharma, Sanjeev, Perry, David, Pablo, John, D’Ambrosio, David J., McKellar, Heidi, Kimsey, Frank C., Chomiak, Paul N., Mahadevan, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348495/ https://www.ncbi.nlm.nih.gov/pubmed/25774243 http://dx.doi.org/10.1007/s13566-014-0177-0 |
Ejemplares similares
-
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry
por: Davis, Joanne N., et al.
Publicado: (2015) -
The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
por: Davis, Joanne N, et al.
Publicado: (2013) -
Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry
por: Mahadevan, Anand, et al.
Publicado: (2018) -
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017) -
Stereotactic Body Radiotherapy for Clinically Localized Prostate Cancer: Toxicity and Biochemical Disease-Free Outcomes from a Multi-Institutional Patient Registry
por: Davis, Joanne, et al.
Publicado: (2015)